Internal restructuring
Location of affected unit(s)
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

2,230 - 2,640 jobs
Number of planned job losses
Job loss
Announcement Date
17 April 2003
Employment effect (start)
1 April 2003
Foreseen end date


Akzo Nobel has reduced its workforce by 2,230 (66,360 on June 30th, 67,880 on December 31th). The company has cut jobs in its three main business areas: pharmacy (approximately 440 jobs lost), coatings (some 1,290 jobs lost) and chemicals( some 450 jobs lost).

February 2004. Diosynth, part of the Pharma branch, has announced a restructuring across the world. To face the declining demand, Diosynth is reducing its capacity by closing its site in Mexico, scaling back facilities in the Netherlands and reducing its production capacity at Buckhaven (Scotland) site. Workforce reductions will directly affect a total of approximately 350 employees. For each site, consultation involving unions and works councils is being, or will be, undertaken as appropriate.

February 2004. 60 jobs to be shed at Akzo Nobel Coatings in Vilvoorde, Belgium.


  • 20 February 2004: Akzo Nobel - Press releases
  • 17 April 2003: Het Financieele Dagblad
  • 18 July 2003: Akzo Nobel - Press releases (www.akzonobel.com)


Eurofound (2003), Akzo Nobel, Internal restructuring in World, factsheet number 59559, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/59559.